Literature DB >> 4317874

Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom.

S H Ferreira, D C Bartelt, L J Greene.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4317874     DOI： 10.1021/bi00815a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  75 in total

1.  Synthesis of bradykinin potentiating pentapeptide (BPP5a).

Authors:  A Ali; M A Guidicci; K Stevenson
Journal:  Experientia       Date:  1976-12-15

2.  Comparative effects of two potentiating peptides (KPP and BPP9a) on kinin-induced rat paw edema.

Authors:  P D Fernandes; J A Guimarães; J Assreuy
Journal:  Agents Actions       Date:  1991-03

3.  Purification and properties of a kininogenin from the venom of Vipera ammodytes ammodytes.

Authors:  G S Bailey; R A Shipolini
Journal:  Biochem J       Date:  1976-02-01       Impact factor: 3.857

4.  Primary structure and biological activity of bradykinin potentiating peptides from Bothrops insularis snake venom.

Authors:  A C Cintra; C A Vieira; J R Giglio
Journal:  J Protein Chem       Date:  1990-04

Review 5.  Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.

Authors:  Ervin G Erdös; Fulong Tan; Randal A Skidgel
Journal:  Hypertension       Date:  2010-01-11       Impact factor: 10.190

6.  Correlation of pulmonary structure with pharmacokinetic function.

Authors:  J W Ryan; U S Ryan
Journal:  Agents Actions       Date:  1976-07

Review 7.  Biological and biochemical properties of angiotensin-converting enzyme.

Authors:  R L Soffer; M Das; P R Caldwell; B C Seegal; K C Hsu
Journal:  Agents Actions       Date:  1976-07

Review 8.  Natural products as a resource for new drugs.

Authors:  A M Clark
Journal:  Pharm Res       Date:  1996-08       Impact factor: 4.200

Review 9.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

10.  Inactivation of bradykinin the plumonary circulation.

Authors:  J M Stewart
Journal:  Agents Actions       Date:  1976-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.